| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/01/2012 | US8168165 Alkylated interleukin-18 compositions |
| 05/01/2012 | US8167866 Drug delivery system for accelerated subcutaneous absorption |
| 05/01/2012 | CA2517888C Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 05/01/2012 | CA2475092C Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 05/01/2012 | CA2455633C Sustained-release therapeutic bioadhesive systems |
| 05/01/2012 | CA2439408C Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor |
| 05/01/2012 | CA2429625C Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 05/01/2012 | CA2379858C Beta-amyloid peptide inhibitors |
| 05/01/2012 | CA2333466C Gbs toxin receptor |
| 05/01/2012 | CA2279555C Amyloid beta protein (globular assembly and uses thereof) |
| 04/26/2012 | WO2012054738A1 Combination of an aminoacyl - trna synthetase inhibitor with a further antibacterial agent for attenuating multiple drug resistance |
| 04/26/2012 | WO2012054071A1 Topical base and active agent-containing compositions, and methods for improving and treating skin |
| 04/26/2012 | WO2012052563A1 Compositions comprising a filler product and a compound of the tetracycline family used at a subantimicrobial dose |
| 04/26/2012 | WO2012052562A1 Compositions comprising a filler product and a chemically modified tetracycline |
| 04/26/2012 | WO2011141783A3 Pharmaceutical composition comprising irbesartan |
| 04/26/2012 | WO2011107922A3 Extended release composition of milnacipran |
| 04/26/2012 | WO2011074015A3 Composition of pharmaceutical product to treat sexual dysfunction |
| 04/26/2012 | WO2009089620A8 Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound |
| 04/26/2012 | US20120101154 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 04/26/2012 | US20120100223 Lipid-containing compositions and methods of use thereof |
| 04/26/2012 | US20120100182 Continuous Cell Programming Devices |
| 04/26/2012 | US20120100156 Therapeutic Agent |
| 04/26/2012 | CA2815299A1 Compositions comprising a filler product and a compound of the tetracycline family used at a subantimicrobial dose |
| 04/25/2012 | EP2444409A2 Compositions and methods for the treatment of immune related diseases |
| 04/25/2012 | EP2444105A1 Anti-gram-negative bacteria agent |
| 04/25/2012 | EP2444089A2 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 04/25/2012 | EP2443120A2 New crystalline form of pemirolast |
| 04/25/2012 | EP2442808A2 Composition for transporting orotic acid across the blood-brain barrier |
| 04/25/2012 | EP2442797A1 Dendrimer based nanodevices for therapeutic and imaging purposes |
| 04/25/2012 | EP2442785A1 Agent for preventing or treating abnormality in skin water permeation function |
| 04/25/2012 | EP2442657A1 Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders |
| 04/25/2012 | EP2442651A1 Treatment of multiple sclerosis with laquinimod |
| 04/25/2012 | EP1909600B1 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 04/25/2012 | EP1879656B1 Pharmaceutical composition comprising an antitumoral agent and an active agent selected especially among carveol, thymol and carvacrol |
| 04/25/2012 | EP1720536B1 Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome |
| 04/25/2012 | EP1658079B1 Multivitamin syrup for children or young adults |
| 04/25/2012 | EP1383490B1 Combination of an epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases |
| 04/25/2012 | CN1953762B Gst活化的抗癌化合物在制备改善铂类化合物的抗癌副作用的药物中的用途 Gst-activated anticancer compound in the preparation of the platinum compounds to improve the side effect of anticancer drugs in use |
| 04/25/2012 | CN1891298B 用于胃肠外、尤其是血管内药物释放的药物贮库 For parenteral, in particular intravascular drug reservoir of drug release |
| 04/25/2012 | CN1805758B Nucleotide and cellular vaccine composition |
| 04/25/2012 | CN1578688B Method and apparatus for the photomodulation of living cells |
| 04/25/2012 | CN1537014B HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases |
| 04/25/2012 | CN1278733B Viscous compositions containing carbon dioxide |
| 04/25/2012 | CN102427808A 基于作为细胞因子活性的活化剂或抑制剂的硫酸化透明质酸的新的用于局部应用的药剂 New medicament for topical application based on the activity of cytokines as activators or inhibitors of the sulfated hyaluronic acid |
| 04/25/2012 | CN102424698A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 04/25/2012 | CN102424680A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 04/25/2012 | CN102424668A 氮杂肽衍生物 Aza-peptide derivatives |
| 04/25/2012 | CN102423507A 一种放射性核素标记的载药生物高分子纳米纤维膜、制备方法及其用途 Drug biopolymer radionuclide labeled nanofiber membrane preparation method and use thereof |
| 04/25/2012 | CN102423491A 一种聚胺型两亲嵌段聚电解质在制备药物载体中的应用 An amphiphilic block polyamine type polyelectrolyte used in the preparation of the drug carrier |
| 04/25/2012 | CN102423489A 组织蛋白酶l抑制剂在制备放疗增敏药物中的应用 Cathepsin inhibitors in the preparation of l radiosensitization drug application |
| 04/25/2012 | CN102423488A 一种治疗带状疱疹的药物组合物 A method of treating herpes zoster in a pharmaceutical composition |
| 04/25/2012 | CN102051016B 可降解的双亲性三嵌段共聚物胶束及其制备方法和用途 Biodegradable amphiphilic triblock copolymer micelles and their preparation and use |
| 04/25/2012 | CN101732724B 一种携载抗肿瘤药物的复合胶束及其制备方法 One kind of carrying antineoplastic complex micelles and its preparation method |
| 04/25/2012 | CN101590240B 含血管紧张素Ⅱ受体拮抗剂、他汀和叶酸的组合物及用途 Containing angiotensin Ⅱ receptor antagonists, statins and folic acid compositions and uses |
| 04/25/2012 | CN101347620B 一种药物组合物及其在制备治疗青光眼的药物中的应用 A pharmaceutical composition for the treatment of glaucoma and pharmaceutical application in the preparation of |
| 04/24/2012 | US8163805 Small molecule antagonists of Bcl-2 family proteins |
| 04/24/2012 | US8163734 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses |
| 04/24/2012 | US8163733 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 04/24/2012 | US8163307 Controlled release compositions for interferon based PEGT/PBT block copolymers and method for preparation thereof |
| 04/24/2012 | US8162873 Apparatus for administering a therapeutic agent into tissue |
| 04/24/2012 | CA2700314C Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 04/24/2012 | CA2645467C Pyridine derivative having anti-helicobacter pylori activity |
| 04/24/2012 | CA2614171C Copolymers for suppression of autoimmune diseases, and methods of use |
| 04/24/2012 | CA2542834C Conjugates or co-administration of igf-1 receptor ligands with anti-cancer chemotherapeutic agents |
| 04/24/2012 | CA2525373C Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 04/24/2012 | CA2472190C Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 04/24/2012 | CA2465132C Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
| 04/24/2012 | CA2456601C Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| 04/24/2012 | CA2439149C Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/24/2012 | CA2408752C Delivery systems for treatment of vascular disease |
| 04/19/2012 | WO2012050184A1 Sustained-release pharmaceutical composition |
| 04/19/2012 | WO2012049566A1 Combination therapy for use in treating diabetes |
| 04/19/2012 | WO2012049504A1 Yeast-derived feed additive |
| 04/19/2012 | WO2012049444A1 Pharmaceutical composition |
| 04/19/2012 | WO2012048710A1 Combinations of serotonin receptor agonists for treatment of movement disorders |
| 04/19/2012 | WO2012022796A3 Novel combinations |
| 04/19/2012 | WO2011104588A3 Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
| 04/19/2012 | US20120095277 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 04/19/2012 | US20120095117 GALECTIN-3 nsSNP MARKER FOR CANCER |
| 04/19/2012 | US20120095018 5-ht1a receptor subtype agonist |
| 04/19/2012 | US20120095017 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors |
| 04/19/2012 | US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 04/19/2012 | US20120094960 Dosage forms of risedronate |
| 04/19/2012 | US20120094938 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease |
| 04/19/2012 | US20120094293 PGC-1ß, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 04/19/2012 | US20120093910 Non-hormonal vaginal contraceptive |
| 04/19/2012 | US20120093856 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 04/19/2012 | US20120093838 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy |
| 04/19/2012 | US20120093784 Compositions and methods for controlling stem cell and tumor cell differentiation, growth, and formation |
| 04/19/2012 | CA2814450A1 Yeast-derived feed additive |
| 04/19/2012 | CA2814445A1 Pharmaceutical composition |
| 04/19/2012 | CA2813648A1 Combinations of serotonin receptor agonists for treatment of movement disorders |
| 04/18/2012 | EP2441760A1 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity |
| 04/18/2012 | EP2441464A1 Specific therapy and medicament using integrin ligands for treating cancer |
| 04/18/2012 | EP2441460A1 GLP-1 pharmaceutical compositions |
| 04/18/2012 | EP2440213A1 Use of 1,25-dihydroxyvitamine d3 glycoside in lactating animals. |
| 04/18/2012 | EP2440201A1 Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders |
| 04/18/2012 | EP2440195A1 Use of alkylglycerols for preparing drugs |
| 04/18/2012 | EP2440165A1 Otic foam formulations |
| 04/18/2012 | EP1830856B1 Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems |